BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:30 PM
 | 
Jul 18, 2007
 |  BC Extra  |  Company News

Pfizer resubmits dalbavancin NDA

PFE disclosed that in June it resubmitted an NDA to FDA for dalbavancin to treat skin...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >